z-logo
open-access-imgOpen Access
The Development of Novel Apurinic/Aprymidinic Endonuclease/Redox-factor 1 Inhibitors for the Treatment of Human Melanoma
Author(s) -
Bella Sharifi
Publication year - 2020
Language(s) - English
Resource type - Dissertations/theses
DOI - 10.36837/chapman.000103
Subject(s) - ap site , dna (apurinic or apyrimidinic site) lyase , endonuclease , transcription factor , dna , dna repair , cancer research , dna damage , ap endonuclease , biology , chemistry , microbiology and biotechnology , biochemistry , gene

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here